Swedish heart failure startup Acorai closes €4.1 million to change the paradigm on acute care settings

Published on January 30, 2024

Helsingborg-based Acorai, a startup medical device manufacturer from Sweden, has announced closing an oversubscribed €4.1 million seed round led by Solardis Health Ventures, with participation from KHP Ventures, Carma Fund and other US investors. Significant follow-on investment was taken from existing investors from across Sweden and the EU. The capital will help to finance its…

This content is for members only. Visit the site and log in/register to read.

The post Swedish heart failure startup Acorai closes €4.1 million to change the paradigm on acute care settings appeared first on EU-Startups.